These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model. Rosenblad C; Kirik D; Björklund A Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072 [TBL] [Abstract][Full Text] [Related]
43. l-DOPA-induced dyskinesia is associated with a deficient numerical downregulation of striatal tyrosine hydroxylase mRNA-expressing neurons. Klietz M; Keber U; Carlsson T; Chiu WH; Höglinger GU; Weihe E; Schäfer MK; Depboylu C Neuroscience; 2016 Sep; 331():120-33. PubMed ID: 27320210 [TBL] [Abstract][Full Text] [Related]
44. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway. Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643 [TBL] [Abstract][Full Text] [Related]
45. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease. Oiwa Y; Yoshimura R; Nakai K; Itakura T Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170 [TBL] [Abstract][Full Text] [Related]
46. Transient and widespread astroglial activation in the brain after a striatal 6-OHDA-induced partial lesion of the nigrostriatal system. Gomide VC; Silveira GA; Chadi G Int J Neurosci; 2005 Jan; 115(1):99-117. PubMed ID: 15768855 [TBL] [Abstract][Full Text] [Related]
47. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats. Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890 [TBL] [Abstract][Full Text] [Related]
48. Reduced TH expression and α-synuclein accumulation contribute towards nigrostriatal dysfunction in experimental hepatic encephalopathy. Suárez I; Bodega G; Rubio M; Fernández B Restor Neurol Neurosci; 2017; 35(5):469-481. PubMed ID: 28984618 [TBL] [Abstract][Full Text] [Related]
49. Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model. Park HJ; Lim S; Joo WS; Yin CS; Lee HS; Lee HJ; Seo JC; Leem K; Son YS; Kim YJ; Kim CJ; Kim YS; Chung JH Exp Neurol; 2003 Mar; 180(1):93-8. PubMed ID: 12668152 [TBL] [Abstract][Full Text] [Related]
50. Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra. Dentresangle C; Le Cavorsin M; Savasta M; Leviel V Brain Res; 2001 Mar; 893(1-2):178-85. PubMed ID: 11223005 [TBL] [Abstract][Full Text] [Related]
51. Inhibition of striatal energy metabolism produces cell loss in the ipsilateral substantia nigra. Sonsalla PK; Manzino L; Sinton CM; Liang CL; German DC; Zeevalk GD Brain Res; 1997 Oct; 773(1-2):223-6. PubMed ID: 9409726 [TBL] [Abstract][Full Text] [Related]
52. Increased activity and expression of tyrosine hydroxylase in the rat substantia nigra after chronic treatment with nomifensine. Rodríguez-Gómez JA; Romero-Ramos M; Vizuete ML; Venero JL; Cano J; Machado A Mol Pharmacol; 1997 Oct; 52(4):641-7. PubMed ID: 9380027 [TBL] [Abstract][Full Text] [Related]
53. Characterization of fetal antigen 1/delta-like 1 homologue expressing cells in the rat nigrostriatal system: effects of a unilateral 6-hydroxydopamine lesion. Liechti R; Ducray AD; Jensen P; Di Santo S; Seiler S; Jensen CH; Meyer M; Widmer HR PLoS One; 2015; 10(2):e0116088. PubMed ID: 25723595 [TBL] [Abstract][Full Text] [Related]
54. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage. Zhang WQ; Tilson HA; Nanry KP; Hudson PM; Hong JS; Stachowiak MK Brain Res; 1988 Oct; 461(2):335-42. PubMed ID: 3141002 [TBL] [Abstract][Full Text] [Related]
55. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Przedborski S; Levivier M; Jiang H; Ferreira M; Jackson-Lewis V; Donaldson D; Togasaki DM Neuroscience; 1995 Aug; 67(3):631-47. PubMed ID: 7675192 [TBL] [Abstract][Full Text] [Related]
56. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion. Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980 [TBL] [Abstract][Full Text] [Related]
57. Delayed plasticity of the mesolimbic dopamine system following neonatal 6-OHDA lesions. Frohna PA; Neal-Beliveau BS; Joyce JN Synapse; 1997 Mar; 25(3):293-305. PubMed ID: 9068128 [TBL] [Abstract][Full Text] [Related]
58. Anatomical and electrophysiological changes in striatal TH interneurons after loss of the nigrostriatal dopaminergic pathway. Ünal B; Shah F; Kothari J; Tepper JM Brain Struct Funct; 2015 Jan; 220(1):331-49. PubMed ID: 24173616 [TBL] [Abstract][Full Text] [Related]
59. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons. Rothblat DS; Schneider JS Brain Res; 1998 Jan; 779(1-2):226-30. PubMed ID: 9473679 [TBL] [Abstract][Full Text] [Related]
60. 6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor. Bowenkamp KE; David D; Lapchak PL; Henry MA; Granholm AC; Hoffer BJ; Mahalik TJ Exp Brain Res; 1996 Sep; 111(1):1-7. PubMed ID: 8891630 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]